Every large medicine procurement in a low-resource health system starts with a number: how many doses, of what, delivered when. Arriving at that number is called quantification, and it sits at a specific point in the logistics cycle—after a program decides which products it will supply, and before anyone signs a purchase order. Programs financed by organizations such as USAID, PEPFAR, and the Global Fund lean heavily on quantification to decide what to buy and when, yet stockouts of essential medicines remain a persistent complaint from clinics that were supposedly counted for. Understanding why requires looking at what quantification actually estimates, and where the estimate and the shelf stop matching.
What Quantification Actually Estimates
Quantification is not a single calculation. It combines forecasting—projecting how much of a product will be needed over a coming period—with supply planning, which turns that forecast into an actual delivery schedule against lead times, funding cycles, and existing stock on hand. Done well, it answers two separate questions: how much demand is coming, and how that demand should be translated into shipments that arrive before the current stock runs out. The distinction matters because a program can forecast demand accurately and still stock out if the supply plan underestimates how long a shipment takes to clear customs, get warehoused, and reach a district store.
Two Forecasting Methods, Two Very Different Inputs
Health programs generally lean on one of two quantification methods, and the choice depends entirely on what data actually exists.
| Method | What it uses | Best suited for | Main weakness |
|---|---|---|---|
| Consumption method | Historical dispensing or issue records, adjusted for past stockouts and expiry | Established treatments with reliable, complete records | Inherits any past stockouts or reporting gaps as if they were true low demand |
| Morbidity method | Expected patient numbers, disease incidence or prevalence, standard treatment guidelines | New medicines, new programs, or settings with no usable consumption history | Only as accurate as the epidemiological estimates and guideline assumptions feeding it |
Neither method is inherently more accurate; they are answers to different data problems. A program with years of clean dispensing records at every facility can trust a consumption-based forecast. A program launching a new intervention, or working where facility-level reporting is thin, has little choice but to build a forecast from expected caseload instead—and to accept the extra uncertainty that comes with it.
Where the Math Breaks Down Before the Truck Ever Leaves
Even a well-built forecast degrades on contact with the data infrastructure underneath it. Logistics and health management information systems that are not updated in real time feed the quantification exercise stale numbers. Where ordering, warehousing, and consumption tracking run on separate spreadsheets or disconnected software, the people doing the quantification are working from a picture that was already out of date when they started. A related and less obvious problem is inventory that is technically in the country but invisible to the channel that needs it—stock sitting in one program’s warehouse that another program’s planners cannot see, which produces what amounts to an artificial stockout even while total national stock looks adequate on paper.
Supply-Side Failures No Forecast Can Fix
A correct forecast still depends on the supply chain executing against it. Manufacturing delays, raw material shortages, and late or incomplete shipments from suppliers can hold up delivery regardless of how precisely the demand side was estimated. Long procurement cycles and approval processes that do not build in automatic reorder points mean that even a program that sees a shortage coming may not be able to act on that warning in time. Underlying all of this are structural constraints particular to low-resource settings: storage and warehousing capacity that cannot absorb bulk deliveries cleanly, transportation networks vulnerable to weather and road conditions, and health system funding that depends heavily on external financing—so that a funding gap at the donor level can stall procurement and technical assistance even when the quantification itself was sound.
What This Means for Anyone Evaluating a Supply Chain
The practical implication for anyone reviewing a program’s medicine security, whether a donor, an implementing partner, or a facility manager, is that a good quantification exercise is necessary but not sufficient. It is worth asking which method produced the current forecast and why, how recently the underlying consumption or morbidity data was updated, and whether the supply plan built on top of that forecast accounts for realistic lead times rather than best-case ones. A forecast that is technically correct on the day it is calculated can still leave a clinic empty-handed months later if the shipment behind it never adjusts for a late supplier, a funding shortfall, or a warehouse that was already full. Quantification reduces guesswork; it does not replace the operational work of getting the resulting order onto a shelf.